United States · FDA National Drug Code directory
CITALOPRAM HYDROBROMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-112_4c38f808-9a23-b5b5-e063-6394a90ae44b
- Product NDC
- 43353-112
- Form
- TABLET
- Composition / generic term
- CITALOPRAM
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121001
- Source listing expiry
- 20271231
Source-listed ingredients
- CITALOPRAM HYDROBROMIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (43353-112-15) · 43353-112-15
- 30 TABLET in 1 BOTTLE (43353-112-30) · 43353-112-30
- 45 TABLET in 1 BOTTLE (43353-112-45) · 43353-112-45
- 60 TABLET in 1 BOTTLE (43353-112-53) · 43353-112-53
- 90 TABLET in 1 BOTTLE (43353-112-60) · 43353-112-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →